F. Crocerossa

Papers

1

Total Citations

3

H-Index

1

About

F. Crocerossa is a urologic surgeon and researcher whose work centers on the surgical management of renal cell carcinoma, with a particular focus on minimally invasive techniques for complex kidney tumors. His major contributions lie in comparing the oncologic and functional outcomes of robot-assisted partial nephrectomy (RAPN) versus percutaneous ablation for challenging renal masses. In his most-cited study, a multicenter analysis with a minimum three-year follow-up, Crocerossa demonstrated that RAPN offers superior local tumor control for completely endophytic renal masses, providing critical evidence to guide treatment selection for these difficult-to-manage tumors. Though early in his career, his work has already garnered attention within the urologic oncology community, with his landmark paper cited three times—a notable impact for a recent publication. Crocerossa’s research is distinguished by its rigorous methodology and direct clinical relevance, helping to refine the risk-benefit calculus for patients with small renal masses. His ongoing investigations continue to shape best practices in nephron-sparing surgery, positioning him as an emerging authority in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted partial nephrectomy versus percutaneous ablation for completely endophytic renal masses: a multicenter analysis with a minimum 3-year follow-up
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago